Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chuck Harrell

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Scientific Reports|September 22, 2023
Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancerHolly A Byers, Amy N Brooks, Janakiram R Vangala, et al.
Cell Reports|September 15, 2015
Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial CellsChristopher Dravis, Benjamin T Spike, J Chuck Harrell, et al.
NPJ Breast Cancer|March 27, 2021
The human intermediate prolactin receptor is a mammary proto-oncogeneJacqueline M Grible, Patricija Zot, Amy L Olex, et al.
Breast Cancer Research : BCR|June 25, 2020
New generation breast cancer cell lines developed from patient-derived xenograftsJessica Finlay-Schultz, Britta M Jacobsen, Duncan Riley, et al.
Breast Cancer Research and Treatment|October 29, 2013
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesAleix Prat, Olga Karginova, Joel S Parker, et al.
ACS Omega|January 8, 2019
Live Cell Mass Accumulation Measurement Non-Invasively Predicts Carboplatin Sensitivity in Triple-Negative Breast Cancer Patient-Derived XenograftsGraeme F Murray, Tia H Turner, Kevin A Leslie, et al.
Bioinformatics (Oxford, England)|April 17, 2023
excluderanges: exclusion sets for T2T-CHM13, GRCm39, and other genome assembliesJonathan D Ogata, Wancen Mu, Eric S Davis, et al.
The Journal of Clinical Investigation|April 3, 2012
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancerChu-An Wang, Paul Jedlicka, Aaron N Patrick, et al.
Translational Oncology|October 10, 2021
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancerNarmeen S Rashid, Nicole S Hairr, Graeme Murray, et al.
Breast Cancer Research and Treatment|December 19, 2012
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous featuresPurevsuren Jambal, Melanie M Badtke, J Chuck Harrell, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Scientific Reports|September 22, 2023
Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancerHolly A Byers, Amy N Brooks, Janakiram R Vangala, et al.
Cell Reports|September 15, 2015
Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial CellsChristopher Dravis, Benjamin T Spike, J Chuck Harrell, et al.
NPJ Breast Cancer|March 27, 2021
The human intermediate prolactin receptor is a mammary proto-oncogeneJacqueline M Grible, Patricija Zot, Amy L Olex, et al.
Breast Cancer Research : BCR|June 25, 2020
New generation breast cancer cell lines developed from patient-derived xenograftsJessica Finlay-Schultz, Britta M Jacobsen, Duncan Riley, et al.
Breast Cancer Research and Treatment|October 29, 2013
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesAleix Prat, Olga Karginova, Joel S Parker, et al.
ACS Omega|January 8, 2019
Live Cell Mass Accumulation Measurement Non-Invasively Predicts Carboplatin Sensitivity in Triple-Negative Breast Cancer Patient-Derived XenograftsGraeme F Murray, Tia H Turner, Kevin A Leslie, et al.
Bioinformatics (Oxford, England)|April 17, 2023
excluderanges: exclusion sets for T2T-CHM13, GRCm39, and other genome assembliesJonathan D Ogata, Wancen Mu, Eric S Davis, et al.
The Journal of Clinical Investigation|April 3, 2012
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancerChu-An Wang, Paul Jedlicka, Aaron N Patrick, et al.
Translational Oncology|October 10, 2021
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancerNarmeen S Rashid, Nicole S Hairr, Graeme Murray, et al.
Breast Cancer Research and Treatment|December 19, 2012
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous featuresPurevsuren Jambal, Melanie M Badtke, J Chuck Harrell, et al.
Pageof 8